CRADBS Stock Overview
Develops, manufactures, and sells products and systems with applications in radiotherapy for the treatment of cancer in Europe, the Middle East, Africa, the America, and the Asia Pacific. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 5/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
C-Rad AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 45.95 |
| 52 Week High | SEK 45.95 |
| 52 Week Low | SEK 45.95 |
| Beta | 1.14 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -8.92% |
Recent News & Updates
Recent updates
Shareholder Returns
| CRADBS | GB Medical Equipment | GB Market | |
|---|---|---|---|
| 7D | 0% | -3.5% | -2.6% |
| 1Y | n/a | -10.6% | 2.4% |
Return vs Industry: Insufficient data to determine how CRADBS performed against the UK Medical Equipment industry.
Return vs Market: Insufficient data to determine how CRADBS performed against the UK Market.
Price Volatility
| CRADBS volatility | |
|---|---|
| CRADBS Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 6.5% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 10.6% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: CRADBS has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine CRADBS's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | 70 | Tim Thurn | www.c-rad.com |
C-Rad AB (publ), together with its subsidiaries, develops, manufactures, and sells systems with applications in radiation therapy for the treatment of cancer worldwide. The company operates through two segments, Positioning and Imaging. Its products include Sentinel 4D CT, a laser-based optical surface scanning system; Catalyst, a 4D surface image guided radiation therapy (SIGRT) solution; Catalyst HD, an SIGRT solution on stereotactic radiation therapy for online patient tracking before and during treatment delivery; Catalyst+, an SIGRT solution for high precision patient positioning, intra-fraction motion management, and respiratory gating; and Catalyst+ HD, a solution for high precision patient positioning, intra-fraction motion management, and respiratory gating for conventional and stereotactic treatment delivery.
C-Rad AB (publ) Fundamentals Summary
| CRADBS fundamental statistics | |
|---|---|
| Market cap | SEK 1.13b |
| Earnings (TTM) | SEK 12.20m |
| Revenue (TTM) | SEK 259.65m |
93.0x
P/E Ratio4.4x
P/S RatioIs CRADBS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CRADBS income statement (TTM) | |
|---|---|
| Revenue | SEK 259.65m |
| Cost of Revenue | SEK 85.32m |
| Gross Profit | SEK 174.33m |
| Other Expenses | SEK 162.13m |
| Earnings | SEK 12.20m |
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
Oct 28, 2022
| Earnings per share (EPS) | 0.36 |
| Gross Margin | 67.14% |
| Net Profit Margin | 4.70% |
| Debt/Equity Ratio | 0% |
How did CRADBS perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2022/09/06 05:42 |
| End of Day Share Price | 2022/06/09 00:00 |
| Earnings | 2022/06/30 |
| Annual Earnings | 2021/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
C-Rad AB (publ) is covered by 2 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Victor Forssell | ABG Sundal Collier Sponsored |
| Christian Lee | Pareto Securities |